Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1178426

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1178426

MEA Pingueculum Drugs Market - Industry Trends and Forecast to 2029

PUBLISHED:
PAGES: 203 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

The Middle East and Africa pingueculum drugs market is projected to register a substantial CAGR of 4.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation:

Middle East and Africa Pingueculum Drugs Market, By Treatment (Artificial Tears /Topical Lubricants, Steroid Eye Drops, Non-steroidal Anti Inflammatory Drops, and Others), Formulation Type (Eye Drops, Eye Ointments, and Others), Mode of Purchase (Prescription, Over the Counter), Drug Type (Branded, Generics), Population Type (Geriatric, Adults), End User (Hospitals, Speciality Clinics, Home Healthcare, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, and Rest of the Middle East and Africa) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the global pingueculum drugs market are:

Rise in the prevalence of pingueculum disease around the globe

Rise in the UV exposure to the individuals due to ozone defect casing pingueculum more frequently

Market Players:

Some of the major players operating in the Middle East and Africa pingueculum drugs market are:

Abbvie Inc.

Alcon Inc.

Bausch & Lomb Incorporated

Bayer AG

Johnson & Johnson Consumer Inc.

Novartis AG

OASIS Medical, Inc.

Santen Pharmaceutical Co.

Laboratoires Thea

Zydus Group

TABLE OF CONTENTS

1 INTRODUCTION 43

  • 1.1 OBJECTIVES OF THE STUDY 43
  • 1.2 MARKET DEFINITION 43
  • 1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET 43
  • 1.4 CURRENCY AND PRICING 45
  • 1.5 LIMITATIONS 45
  • 1.6 MARKETS COVERED 46

2 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: SEGMENTATION 48

  • 2.1 MARKETS COVERED 48
  • 2.2 GEOGRAPHICAL SCOPE 49
  • 2.3 YEARS CONSIDERED FOR THE STUDY 50
  • 2.4 CURRENCY AND PRICING 50
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 51
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
  • 2.7 MULTIVARIATE MODELLING 55
  • 2.8 TREATMENT LIFELINE CURVE 55
  • 2.9 DBMR MARKET POSITION GRID 56
  • 2.10 VENDOR SHARE ANALYSIS 58
  • 2.11 MARKET END-USER COVERAGE GRID 59
  • 2.12 SECONDARY SOURCES 60
  • 2.13 ASSUMPTIONS 60

3 EXECUTIVE SUMMARY 61

4 PREMIUM INSIGHTS 64

  • 4.1 EPIDERMIOLOGY 65
  • 4.2 PESTEL ANALYSIS 66
  • 4.3 PORTER'S FIVE FORCES 67
  • 4.4 PIPELINE ANALYSIS FOR THE MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET 68
  • 4.5 INDUSTRIAL INSIGHTS: 69
  • 4.6 CONCLUSION: 69

5 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: REGULATIONS 70

6 MARKET OVERVIEW 73

  • 6.1 DRIVERS 75
    • 6.1.1 RISING PREVALENCE OF PINGUECELA DISORDERS AND OCULAR PAINS 75
    • 6.1.2 RISE IN THE CHRONIC UV RADIATION EXPOSURE DUE TO OZONE DEFECT 75
    • 6.1.3 INCREASING AWARENESS AMONG PEOPLE FOR EYE-RELATED DISEASES 76
    • 6.1.4 RISING OPHTHALMIC EMERGENCIES IN THE GERIATRIC PATIENT 77
  • 6.2 RESTRAINTS 77
    • 6.2.1 STRINGENT RULES & REGULATIONS 77
    • 6.2.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT 78
  • 6.3 OPPORTUNITIES 79
    • 6.3.1 INITIATIVES AND PLANS TO LESSEN THE PREVALENCE OF EYE ILLNESSES 79
    • 6.3.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES 79
    • 6.3.3 INCREASE IN HEALTHCARE SPENDING AND ACCESSIBLE INCOME 80
  • 6.4 CHALLENGES 81
    • 6.4.1 ADVERSE EFFECTS OF STEROID EYE DROPS 81
    • 6.4.2 LACK OF SKILLED OPHTHALMOLOGISTS 82

7 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY TREATMENT 83

  • 7.1 OVERVIEW 84
  • 7.2 ARTIFICIAL TEARS/TOPICAL LUBRICANTS 87
    • 7.2.1 DEMULCENT 87
    • 7.2.2 EMOLLIENTS 87
  • 7.3 STEROID EYE DROPS 88
    • 7.3.1 KETONE STEROIDS 89
      • 7.3.1.1 PREDNISOLONE 89
      • 7.3.1.2 DEXAMETHASONE 89
      • 7.3.1.3 FLUROMETHOLONE 89
      • 7.3.1.4 MEDRYSONE 89
      • 7.3.1.5 RIMEXOLONE 89
      • 7.3.1.6 OTHERS 89
    • 7.3.2 ESTER STEROID (LOTERPREDNOL) 90
  • 7.4 NON-STEROIDAL ANTI-INFLAMMATORY DROPS 90
  • 7.5 OTHERS 90

8 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY FORMULATION 91

  • 8.1 OVERVIEW 92
  • 8.2 EYE DROPS 95
    • 8.2.1 EYE DROPS WITH PRESERVATIVES 95
    • 8.2.2 PRESERVATIVE-FREE EYE DROPS 95
  • 8.3 EYE OINTMENTS 96
    • 8.3.1 WITH PRESERVATIVES 96
    • 8.3.2 PRESERVATIVE-FREE 96
    • 8.3.3 OTHERS 96
  • 8.4 OTHERS 97

9 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, MODE OF PURCHASE 98

  • 9.1 OVERVIEW 99
  • 9.2 PRESCRIPTION 102
  • 9.3 OVER THE COUNTER (OTC) 102

10 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE 103

  • 10.1 OVERVIEW 104
  • 10.2 BRANDED 107
  • 10.3 GENERICS 107

11 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE 108

  • 11.1 OVERVIEW 109
  • 11.2 GERIATRIC 112
    • 11.2.1 MALE 112
    • 11.2.2 FEMALE 112
  • 11.3 ADULTS 113
    • 11.3.1 MALE 113
    • 11.3.2 FEMALE 113

12 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY END USER 114

  • 12.1 OVERVIEW 115
  • 12.2 HOSPITALS 118
  • 12.3 SPECIALTY CLINICS 118
  • 12.4 HOME HEALTHCARE 119
  • 12.5 OTHERS 119

13 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL 120

  • 13.1 OVERVIEW 121
  • 13.2 RETAIL PHARMACIES 124
  • 13.3 HOSPITAL PHARMACIES 124
  • 13.4 ONLINE PHARMACIES 125
  • 13.5 OTHERS 125

14 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY REGION 126

  • 14.1 MIDDLE EAST AND AFRICA 127
    • 14.1.1 SOUTH AFRICA 136
    • 14.1.2 EGYPT 140
    • 14.1.3 ISRAEL 144
    • 14.1.4 U.A.E 148
    • 14.1.5 SAUDI ARABIA 152
    • 14.1.6 KUWAIT 156
    • 14.1.7 REST OF MIDDLE EAST AND AFRICA 160

15 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: COMPANY LANDSCAPE 161

  • 15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 161

16 SWOT ANALYSIS 162

17 COMPANY PROFILE 163

  • 17.1 ALCON INC. 163
    • 17.1.1 COMPANY SNAPSHOT 163
    • 17.1.2 REVENUE ANALYSIS 163
    • 17.1.3 COMPANY SHARE ANALYSIS 164
    • 17.1.4 PRODUCT PORTFOLIO 164
    • 17.1.5 RECENT DEVELOPMENT 164
  • 17.2 ABBVIE INC. 165
    • 17.2.1 COMPANY SNAPSHOT 165
    • 17.2.2 REVENUE ANALYSIS 165
    • 17.2.3 COMPANY SHARE ANALYSIS 166
    • 17.2.4 PRODUCT PORTFOLIO 166
    • 17.2.5 RECENT DEVELOPMENT 167
  • 17.3 BAUSCH & LOMB INCORPORATED 168
    • 17.3.1 COMPANY SNAPSHOT 168
    • 17.3.2 REVENUE ANALYSIS 168
    • 17.3.3 COMPANY SHARE ANALYSIS 169
    • 17.3.4 PRODUCT PORTFOLIO 169
    • 17.3.5 RECENT DEVELOPMENT 170
  • 17.4 BAYER AG 171
    • 17.4.1 COMPANY SNAPSHOT 171
    • 17.4.2 REVENUE ANALYSIS 171
    • 17.4.3 COMPANY SHARE ANALYSIS 172
    • 17.4.4 PRODUCT PORTFOLIO 172
    • 17.4.5 RECENT DEVELOPMENTS 172
  • 17.5 JOHNSON & JOHNSON VISION CARE, INC. 173
    • 17.5.1 COMPANY SNAPSHOT 173
    • 17.5.2 REVENUE ANALYSIS 173
    • 17.5.3 COMPANY SHARE ANALYSIS 174
    • 17.5.4 PRODUCT PORTFOLIO 174
    • 17.5.5 RECENT DEVELOPMENT 174
  • 17.6 AKORN OPERATING COMPANY LLC 175
    • 17.6.1 COMPANY SNAPSHOT 175
    • 17.6.2 . PRODUCT PORTFOLIO 175
    • 17.6.3 RECENT DEVELOPMENT 175
  • 17.7 AMNEAL PHARMACEUTICALS LLC. 176
    • 17.7.1 COMPANY SNAPSHOT 176
    • 17.7.2 REVENUE ANALYSIS 176
    • 17.7.3 PRODUCT PORTFOLIO 177
    • 17.7.4 RECENT DEVELOPMENTS 177
  • 17.8 EYERIS VISIONCARE PVT. LTD. 178
    • 17.8.1 COMPANY SNAPSHOT 178
    • 17.8.2 PRODUCT PORTFOLIO 178
    • 17.8.3 RECENT DEVELOPMENTS 179
  • 17.9 LABORATOIRES THEA 180
    • 17.9.1 COMPANY SNAPSHOT 180
    • 17.9.2 PRODUCT PORTFOLIO 180
    • 17.9.3 RECENT DEVELOPMENT 181
  • 17.10 MAYA BIOTECH PRIVATE LIMITED 182
    • 17.10.1 COMPANY SNAPSHOT 182
    • 17.10.2 PRODUCT PORTFOLIO 182
    • 17.10.3 RECENT DEVELOPMENTS 183
  • 17.11 NOVARTIS AG 184
    • 17.11.1 COMPANY SNAPSHOT 184
    • 17.11.2 REVENUE ANALYSIS 184
    • 17.11.3 PRODUCT PORTFOLIO 185
    • 17.11.4 RECENT DEVELOPMENT 185
  • 17.12 OASIS MEDICAL, INC. 186
    • 17.12.1 COMPANY SNAPSHOT 186
    • 17.12.2 PRODUCT PORTFOLIO 186
    • 17.12.3 RECENT DEVELOPMENT 186
  • 17.13 PRESTIGE CONSUMER HEALTHCARE, INC. 187
    • 17.13.1 COMPANY SNAPSHOT 187
    • 17.13.2 PRODUCT PORTFOLIO 188
    • 17.13.3 RECENT DEVELOPMENT 188
  • 17.14 SAGER PHARMA 189
    • 17.14.1 COMPANY SNAPSHOT 189
    • 17.14.2 PRODUCT PORTFOLIO 189
    • 17.14.3 RECENT DEVELOPMENTS 189
  • 17.15 SANTEN PHARMACEUTICAL CO., LTD. 190
    • 17.15.1 COMPANY SNAPSHOT 190
    • 17.15.2 REVENUE ANALYSIS 190
    • 17.15.3 PRODUCT PORTFOLIO 191
    • 17.15.4 RECENT DEVELOPMENTS 191
  • 17.16 SIMILASAN CORPORATION 192
    • 17.16.1 COMPANY SNAPSHOT 192
    • 17.16.2 PRODUCT PORTFOLIO 192
    • 17.16.3 RECENT DEVELOPMENTS 192
  • 17.17 SPECTRA VISION CARE 193
    • 17.17.1 COMPANY SNAPSHOT 193
    • 17.17.2 PRODUCT PORTFOLIO 193
    • 17.17.3 RECENT DEVELOPMENTS 194
  • 17.18 SYLENTIS 195
    • 17.18.1 COMPANY SNAPSHOT 195
    • 17.18.2 PRODUCT PORTFOLIO 195
    • 17.18.3 RECENT DEVELOPMENTS 195
  • 17.19 WELLONA PHARMA 196
    • 17.19.1 COMPANY SNAPSHOT 196
    • 17.19.2 PRODUCT PORTFOLIO 196
    • 17.19.3 RECENT DEVELOPMENTS 196
  • 17.20 ZYDUS GROUP 197
    • 17.20.1 COMPANY SNAPSHOT 197
    • 17.20.2 REVENUE ANALYSIS 197
    • 17.20.3 PRODUCT PORTFOLIO 198
    • 17.20.4 RECENT DEVELOPMENTS 198

18 QUESTIONNAIRE 199

19 RELATED REPORTS 203

LIST OF TABLES

  • TABLE 1 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 62
  • TABLE 2 MIDDLE EAST & AFRICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 63
  • TABLE 3 MIDDLE EAST & AFRICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 63
  • TABLE 4 MIDDLE EAST & AFRICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 64
  • TABLE 5 MIDDLE EAST & AFRICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 64
  • TABLE 6 MIDDLE EAST & AFRICA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 65
  • TABLE 7 MIDDLE EAST & AFRICA NON-STEROIDAL ANTI-INFLAMMATORY DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 66
  • TABLE 8 MIDDLE EAST & AFRICA OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 66
  • TABLE 9 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 70
  • TABLE 10 MIDDLE EAST & AFRICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 71
  • TABLE 11 MIDDLE EAST & AFRICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 71
  • TABLE 12 MIDDLE EAST & AFRICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 72
  • TABLE 13 MIDDLE EAST & AFRICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 72
  • TABLE 14 MIDDLE EAST & AFRICA OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 73
  • TABLE 15 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 77
  • TABLE 16 MIDDLE EAST & AFRICA PRESCRIPTION IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 78
  • TABLE 17 MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 78
  • TABLE 18 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 82
  • TABLE 19 MIDDLE EAST & AFRICA BRANDED IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 83
  • TABLE 20 MIDDLE EAST & AFRICA GENERICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 83
  • TABLE 21 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 87
  • TABLE 22 MIDDLE EAST & AFRICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 88
  • TABLE 23 MIDDLE EAST & AFRICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 88
  • TABLE 24 MIDDLE EAST & AFRICA ADULTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 89
  • TABLE 25 MIDDLE EAST & AFRICA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 89
  • TABLE 26 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 93
  • TABLE 27 MIDDLE EAST & AFRICA HOSPITALS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 94
  • TABLE 28 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 94
  • TABLE 29 MIDDLE EAST & AFRICA HOME HEALTHCARE IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 95
  • TABLE 30 MIDDLE EAST & AFRICA OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 95
  • TABLE 31 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 99
  • TABLE 32 MIDDLE EAST & AFRICA RETAIL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 100
  • TABLE 33 MIDDLE EAST & AFRICA HOSPITAL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 100
  • TABLE 34 MIDDLE EAST & AFRICA ONLINE PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 101
  • TABLE 35 MIDDLE EAST & AFRICA OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 101
  • TABLE 36 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 108
  • TABLE 37 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 108
  • TABLE 38 MIDDLE EAST AND AFRICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 108
  • TABLE 39 MIDDLE EAST AND AFRICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 109
  • TABLE 40 MIDDLE EAST AND AFRICA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 109
  • TABLE 41 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 109
  • TABLE 42 MIDDLE EAST AND AFRICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 109
  • TABLE 43 MIDDLE EAST AND AFRICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 110
  • TABLE 44 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 110
  • TABLE 45 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 110
  • TABLE 46 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 110
  • TABLE 47 MIDDLE EAST AND AFRICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 111
  • TABLE 48 MIDDLE EAST AND AFRICA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 111
  • TABLE 49 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 111
  • TABLE 50 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 111
  • TABLE 51 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 112
  • TABLE 52 SOUTH AFRICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 112
  • TABLE 53 SOUTH AFRICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 112
  • TABLE 54 SOUTH AFRICA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 113
  • TABLE 55 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 113
  • TABLE 56 SOUTH AFRICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 113
  • TABLE 57 SOUTH AFRICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 114
  • TABLE 58 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 114
  • TABLE 59 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 114
  • TABLE 60 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 114
  • TABLE 61 SOUTH AFRICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 115
  • TABLE 62 SOUTH AFRICA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 115
  • TABLE 63 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 115
  • TABLE 64 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 115
  • TABLE 65 EGYPT PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 116
  • TABLE 66 EGYPT ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 116
  • TABLE 67 EGYPT STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 116
  • TABLE 68 EGYPT KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 117
  • TABLE 69 EGYPT PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 117
  • TABLE 70 EGYPT EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 117
  • TABLE 71 EGYPT EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 118
  • TABLE 72 EGYPT PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 118
  • TABLE 73 EGYPT PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 118
  • TABLE 74 EGYPT PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 118
  • TABLE 75 EGYPT GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 119
  • TABLE 76 EGYPT ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 119
  • TABLE 77 EGYPT PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 119
  • TABLE 78 EGYPT PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 119
  • TABLE 79 ISRAEL PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 120
  • TABLE 80 ISRAEL ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 120
  • TABLE 81 ISRAEL STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 120
  • TABLE 82 ISRAEL KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 121
  • TABLE 83 ISRAEL PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 121
  • TABLE 84 ISRAEL EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 121
  • TABLE 85 ISRAEL EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 122
  • TABLE 86 ISRAEL PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 122
  • TABLE 87 ISRAEL PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 122
  • TABLE 88 ISRAEL PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 122
  • TABLE 89 ISRAEL GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 123
  • TABLE 90 ISRAEL ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 123
  • TABLE 91 ISRAEL PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 123
  • TABLE 92 ISRAEL PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 123
  • TABLE 93 UAE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 124
  • TABLE 94 UAE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 124
  • TABLE 95 UAE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 124
  • TABLE 96 UAE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 125
  • TABLE 97 UAE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 125
  • TABLE 98 UAE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 125
  • TABLE 99 UAE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 126
  • TABLE 100 UAE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 126
  • TABLE 101 U.A.E PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 126
  • TABLE 102 UAE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 126
  • TABLE 103 UAE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 127
  • TABLE 104 UAE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 127
  • TABLE 105 UAE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 127
  • TABLE 106 UAE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 127
  • TABLE 107 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 128
  • TABLE 108 SAUDI ARABIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 128
  • TABLE 109 SAUDI ARABIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 128
  • TABLE 110 SAUDI ARABIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 129
  • TABLE 111 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 129
  • TABLE 112 SAUDI ARABIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 129
  • TABLE 113 SAUDI ARABIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 130
  • TABLE 114 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 130
  • TABLE 115 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 130
  • TABLE 116 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 130
  • TABLE 117 SAUDI ARABIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 131
  • TABLE 118 SAUDI ARABIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 131
  • TABLE 119 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 131
  • TABLE 120 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 131
  • TABLE 121 KUWAIT PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 132
  • TABLE 122 KUWAIT ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 132
  • TABLE 123 KUWAIT STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 132
  • TABLE 124 KUWAIT KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 133
  • TABLE 125 KUWAIT PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 133
  • TABLE 126 KUWAIT EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 133
  • TABLE 127 KUWAIT EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 134
  • TABLE 128 KUWAIT PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 134
  • TABLE 129 KUWAIT PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 134
  • TABLE 130 KUWAIT PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 134
  • TABLE 131 KUWAIT GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 135
  • TABLE 132 KUWAIT ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 135
  • TABLE 133 KUWAIT PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 135
  • TABLE 134 KUWAIT PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 135
  • TABLE 135 REST OF MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 136

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: SEGMENTATION 23
  • FIGURE 2 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: DATA TRIANGULATION 26
  • FIGURE 3 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: DROC ANALYSIS 27
  • FIGURE 4 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 28
  • FIGURE 5 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: COMPANY RESEARCH ANALYSIS 28
  • FIGURE 6 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: INTERVIEW DEMOGRAPHICS 29
  • FIGURE 7 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: DBMR POSITION GRID 31
  • FIGURE 8 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: VENDOR SHARE ANALYSIS 33
  • FIGURE 9 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: END USER COVERAGE GRID 34
  • FIGURE 10 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: SEGMENTATION 38
  • FIGURE 11 INCREASING PREVALENCE OF OPHTHALMIC DISORDERS AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET GROWTH FROM 2022 TO 2029 39
  • FIGURE 12 ARTIFICIAL TEARS/TOPICAL LUBRICANTS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET FROM 2022 & 2029 39
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET 49
  • FIGURE 14 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY TREATMENT, 2021 59
  • FIGURE 15 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY TREATMENT, 2022-2029 (USD MILLION) 60
  • FIGURE 16 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY TREATMENT, CAGR (2022-2029) 60
  • FIGURE 17 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY TREATMENT, LIFELINE CURVE 61
  • FIGURE 18 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY FORMULATION, 2021 67
  • FIGURE 19 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY FORMULATION, 2022-2029 (USD MILLION) 68
  • FIGURE 20 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY FORMULATION, CAGR (2022-2029) 68
  • FIGURE 21 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY FORMULATION, LIFELINE CURVE 69
  • FIGURE 22 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2021 74
  • FIGURE 23 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2022-2029 (USD MILLION) 75
  • FIGURE 24 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, CAGR (2022-2029) 75
  • FIGURE 25 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, LIFELINE CURVE 76
  • FIGURE 26 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2021 79
  • FIGURE 27 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2022-2029 (USD MILLION) 80
  • FIGURE 28 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, CAGR (2022-2029) 80
  • FIGURE 29 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, LIFELINE CURVE 81
  • FIGURE 30 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2021 84
  • FIGURE 31 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2022-2029 (USD MILLION) 85
  • FIGURE 32 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, CAGR (2022-2029) 85
  • FIGURE 33 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, LIFELINE CURVE 86
  • FIGURE 34 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY END USER, 2021 90
  • FIGURE 35 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION) 91
  • FIGURE 36 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY END USER, CAGR (2022-2029) 91
  • FIGURE 37 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY END USER, LIFELINE CURVE 92
  • FIGURE 38 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021 96
  • FIGURE 39 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 97
  • FIGURE 40 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 97
  • FIGURE 41 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 98
  • FIGURE 42 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: SNAPSHOT (2021) 103
  • FIGURE 43 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021) 105
  • FIGURE 44 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029) 105
  • FIGURE 45 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029) 106
  • FIGURE 46 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029) 106
  • FIGURE 47 MIDDLE EAST & AFRICA PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%) 136
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!